Guidance

Rotavirus vaccine (Rotarix®): patient group direction (PGD) template

Patient group direction template to support the national rotavirus (Rotarix®) vaccination programme for infants.

• From: UK Health Security Agency
• Published: 30 June 2015
• Last updated: 31 May 2023 — See all updates

Applies to England

Documents

Rotavirus vaccine (Rotarix®) PGD template

Ref: UKHSA gateway number GOV-14754

MS Word Document, 129 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template is to support the rotavirus vaccination programme.

Rotavirus PGD version 6.00 is valid from 30 June 2023 to 30 June 2025.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement see Human Medicines Regulations 2012. Practitioners should follow local policy/procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics.

Published 30 June 2015
Last updated 31 May 2023 + show all updates

1. 31 May 2023

   Added version 6.00 - see page 2 for change history.

2. 4 June 2021

   Added version 05.00 - see page 2 for change history.

3. 3 June 2019

   Added routine review and update of PGD.

4. 23 May 2017

   Added revised PGD v03.00 to replace expiring v02.00 from 1 July 2017.

5. 30 June 2015

   First published.